SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-060244
Filing Date
2023-11-07
Accepted
2023-11-07 16:10:08
Documents
13
Period of Report
2023-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alec-20231107.htm   iXBRL 8-K 46886
2 EX-99.1 alec-ex99_1.htm EX-99.1 158683
  Complete submission text file 0000950170-23-060244.txt   332185

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alec-20231107_pre.xml EX-101.PRE 9833
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alec-20231107.xsd EX-101.SCH 2454
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alec-20231107_lab.xml EX-101.LAB 13360
7 EXTRACTED XBRL INSTANCE DOCUMENT alec-20231107_htm.xml XML 4686
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 231383794
SIC: 2836 Biological Products, (No Diagnostic Substances)